Skip to main content
Home / News and Insights / News / Bircham Dyson Bell advises ImmuPharma PLC on its £10 million fundraising
Bircham Dyson Bell (BDB) LLP and Pitmans LLP merged on 1 December 2018 to become BDB Pitmans LLP. More details can be found here
25 January 2018

Bircham Dyson Bell advises ImmuPharma PLC on its £10 million fundraising

Bircham Dyson Bell acted for ImmuPharma PLC, the AIM-listed specialist drug discovery and development company, in relation to its fundraising, which raised £10 million by way of a share subscription and placing with new and existing shareholders.

The transaction was led by corporate partner Philip Lamb and senior associate Tessa Trevelyan Thomas.

Philip Lamb comments:

‘We are delighted by the successful outcome of this fundraising at an exciting stage of the company’s development, and to be continuing our long-standing relationship with the company dating back to before it floated in 2006.’

Related Articles

London and Cambridge Offices

London Westminster
50 Broadway, London
SW1H 0BL

London City
107 Cheapside, London
EC2V 6DN

Cambridge
51 Hills Road, Cambridge
CB2 1NT

Reading and Southampton Offices

Reading, Castle Street
47 Castle Street Berkshire,
Reading RG1 7SR

Reading, The Anchorage
34 Bridge Street Berkshire,
Reading RG1 2LU

Southampton, The Avenue
46 The Avenue Southampton
Southampton SO17 1AX

Follow us

  • Pay my invoice
  • Lexcel
  • CYBER ESSENTIALS PLUS

© BDB Pitmans 2019. 50 Broadway, London, SW1H 0BL - T +44 (0)345 222 9222